Facebook
X
LinkedIn
ForwardBridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Recorded on Thursday, May 14, 2026 at 1-2pm PT
Pricing: Free for Members and Non-Members
Course Description
Transthyretin amyloidosis cardiomyopathy (ATTR‑CM) presents significant clinical and managed care challenges related to delayed diagnosis, complex care pathways, and evolving treatment options. This session examines current and emerging pharmacologic therapies, along with recent evidence, to inform treatment selection and monitoring. Through a multi‑stakeholder discussion, perspectives from clinicians, payers, health systems, and patient representatives are used to highlight opportunities for improved care coordination. Regional variations in access, diagnosis, and managed care operations are explored to identify strategies that support equitable care delivery. Participants will gain practical insights to enhance collaboration and optimize outcomes for patients with ATTR‑CM.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
Discuss recent and emerging pharmacologic therapies and evidence updates in the management of transthyretin amyloidosis cardiomyopathy (ATTR‐CM).
Describe the roles and perspectives of diverse stakeholders—including clinicians, payers, health systems, and patient representatives—in improving coordination and outcomes in ATTR‐CM care.
Examine regional variations in access, diagnosis, and care coordination for patients with ATTR‐CM to identify strategies for optimized managed care collaboration.
Commercial Support
This activity is supported by an independent medical education grant from Alnylam U.S., Inc.
Moderator:
Cecilia Stewart, PharmD
Manager of Clinical Pharmacy
Moda Health
Speakers:
Hongya Chen, PharmD
Cardiology Pharmacist
Oregon Health & Science University KCVI
Kimberly Grant, PharmD
Director of Clinical Pharmacy
IPD Analytics
Ahmad Masri, MD, MS
Director, Hypertrophic Cardiomyopathy Center
Oregon Health & Science University
Erin Poyant
Senior Manager of Education and Awareness
Amyloidosis Research Consortium
Disclosures:
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Hongya Chen | Consulting fees: BridgeBio, cytokinetic |
Kimberly Grant | Speaker honoraria: BridgeBio |
Ahmad Masri | Disclosed no relevant financial relationships. |
Erin Poyant Faculty | Disclosed no relevant financial relationships. |
Cecilia Stewart | Disclosed no relevant financial relationships. |
Drake Reiter Peer Reviewer | Disclosed no relevant financial relationships. |
Angela Cassano Peer Reviewer, Planner | Disclosed no relevant financial relationships. |
Brittany V. Henry | Disclosed no relevant financial relationships. |
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-26-034-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.00
Release Date: June 16, 2026 • Expiration Date: Decemeber 31, 2027
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at the AMCP Northwest Day of Education. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.